{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T16:37:56Z","timestamp":1790267876880,"version":"4.1.0"},"reference-count":90,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,1,8]],"date-time":"2021-01-08T00:00:00Z","timestamp":1610064000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,1,8]],"date-time":"2021-01-08T00:00:00Z","timestamp":1610064000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"National Key Research and Development Program of China","award":["2016YFC0901504"],"award-info":[{"award-number":["2016YFC0901504"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Transl Neurodegener"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Accumulating evidence has suggested that the pathological changes in amyotrophic lateral sclerosis (ALS) are not only confined to the central nervous system but also occur in the peripheral circulating system. Here, we performed a meta-analysis based on the PubMed, EMBASE, EBSCO, and CNKI databases, to find out biochemical indicators associated with energy metabolism, iron homeostasis, and muscle injury that are altered in ALS patients and their correlations with ALS phenotypes. Forty-six studies covering 17 biochemical indicators, representing 5454 ALS patients and 7986 control subjects, were included in this meta-analysis. Four indicators, including fasting blood glucose level (weighted mean difference [WMD] = 0.13, 95% CI [0.06\u20130.21],<jats:italic>p<\/jats:italic>= 0.001), serum ferritin level (WMD = 63.42, 95% CI [48.12\u201378.73],<jats:italic>p<\/jats:italic>&lt;\u20090.001), transferrin saturation coefficient level (WMD = 2.79, 95% CI [1.52\u20134.05],<jats:italic>p<\/jats:italic>&lt;\u20090.001), and creatine kinase level (WMD = 80.29, 95% CI [32.90\u2013127.67],<jats:italic>p<\/jats:italic>&lt;\u20090.001), were significantly higher in the ALS patients, whereas the total iron-binding capacity (WMD = \u2212\u20092.42, 95% CI [\u2212\u20093.93, \u2212\u20090.90],<jats:italic>p<\/jats:italic>= 0.002) was significantly lower in ALS patients than in the control subjects. In contrast, the other 12 candidates did not show significant differences between ALS patients and controls. Moreover, pooled hazard ratios (HR) showed significantly reduced survival (HR = 1.38, 95% CI [1.02\u20131.88],<jats:italic>p<\/jats:italic>= 0.039) of ALS patients with elevated serum ferritin levels. These findings suggest that abnormalities in energy metabolism and disruption of iron homeostasis are involved in the pathogenesis of ALS. In addition, the serum ferritin level is negatively associated with the overall survival of ALS patients.<\/jats:p>","DOI":"10.1186\/s40035-020-00228-9","type":"journal-article","created":{"date-parts":[[2021,1,8]],"date-time":"2021-01-08T07:03:22Z","timestamp":1610089402000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":34,"title":["Aberrations of biochemical indicators in amyotrophic lateral sclerosis: a systematic review and meta-analysis"],"prefix":"10.1186","volume":"10","author":[{"given":"Yangfan","family":"Cheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongping","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0947-1151","authenticated-orcid":false,"given":"Huifang","family":"Shang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,1,8]]},"reference":[{"issue":"9769","key":"228_CR1","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1016\/S0140-6736(10)61156-7","volume":"377","author":"MC Kiernan","year":"2011","unstructured":"Kiernan MC, Vucic S, Cheah BC, Turner MR, Eisen A, Hardiman O, et al. Amyotrophic lateral sclerosis. Lancet. 2011;377(9769):942\u201355.","journal-title":"Lancet."},{"issue":"2","key":"228_CR2","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1056\/NEJMra1603471","volume":"377","author":"RH Brown","year":"2017","unstructured":"Brown RH, Al-Chalabi A. Amyotrophic lateral sclerosis. N Engl J Med. 2017;377(2):162\u201372.","journal-title":"N Engl J Med"},{"issue":"Suppl 1","key":"228_CR3","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1002\/ana.21543","volume":"65","author":"JD Rothstein","year":"2009","unstructured":"Rothstein JD. Current hypotheses for the underlying biology of amyotrophic lateral sclerosis. Ann Neurol. 2009;65(Suppl 1):S3\u20139.","journal-title":"Ann Neurol"},{"issue":"2","key":"228_CR4","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1159\/000351153","volume":"41","author":"A Chi\u00f2","year":"2013","unstructured":"Chi\u00f2 A, Logroscino G, Traynor BJ, Collins J, Simeone JC, Goldstein LA, et al. Global epidemiology of amyotrophic lateral sclerosis: a systematic review of the published literature. Neuroepidemiology. 2013;41(2):118\u201330.","journal-title":"Neuroepidemiology."},{"issue":"3","key":"228_CR5","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1111\/j.1468-1331.2011.03501.x","volume":"19","author":"PM Andersen","year":"2012","unstructured":"Andersen PM, Abrahams S, Borasio GD, de Carvalho M, Chio A, Van Damme P, et al. EFNS guidelines on the clinical management of amyotrophic lateral sclerosis (MALS)--revised report of an EFNS task force. Eur J Neurol. 2012;19(3):360\u201375.","journal-title":"Eur J Neurol"},{"key":"228_CR6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13024-016-0142-z","volume":"12","author":"W Qian-Qian","year":"2017","unstructured":"Qian-Qian W, Yongping C, Bei C, Ru Wei O, Lingyu Z, Yanbing H, et al. Blood hemoglobin A1c levels and amyotrophic lateral sclerosis survival. Mol Neurodegener. 2017;12:1\u20137.","journal-title":"Mol Neurodegener"},{"issue":"5","key":"228_CR7","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1002\/ana.24936","volume":"81","author":"D Mariosa","year":"2017","unstructured":"Mariosa D, Hammar N, Malmstr\u00f6m H, Ingre C, Jungner I, Ye W, et al. Blood biomarkers of carbohydrate, lipid, and apolipoprotein metabolisms and risk of amyotrophic lateral sclerosis: a more than 20-year follow-up of the Swedish AMORIS cohort. Ann Neurol. 2017;81(5):718\u201328.","journal-title":"Ann Neurol"},{"issue":"1\u20132","key":"228_CR8","doi-asserted-by":"publisher","first-page":"166","DOI":"10.3109\/17482960902822960","volume":"11","author":"PF Pradat","year":"2010","unstructured":"Pradat PF, Bruneteau G, Gordon PH, Dupuis L, Bonnefont-Rousselot D, Simon D, et al. Impaired glucose tolerance in patients with amyotrophic lateral sclerosis. Amyotroph Lateral Scler. 2010;11(1\u20132):166\u201371.","journal-title":"Amyotroph Lateral Scler"},{"key":"228_CR9","doi-asserted-by":"publisher","first-page":"284","DOI":"10.3389\/fneur.2019.00284","volume":"10","author":"JL Gonz\u00e1lez De Aguilar","year":"2019","unstructured":"Gonz\u00e1lez De Aguilar JL. Lipid biomarkers for amyotrophic lateral sclerosis. Front Neurol. 2019;10:284.","journal-title":"Front Neurol"},{"key":"228_CR10","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.neurobiolaging.2018.03.022","volume":"67","author":"X Chen","year":"2018","unstructured":"Chen X, Yazdani S, Piehl F, Magnusson PKE, Fang F. Polygenic link between blood lipids and amyotrophic lateral sclerosis. Neurobiol Aging. 2018;67:202 e1-.e6.","journal-title":"Neurobiol Aging"},{"issue":"1","key":"228_CR11","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1194\/jlr.P071639","volume":"58","author":"J Abdel-Khalik","year":"2017","unstructured":"Abdel-Khalik J, Yutuc E, Crick PJ, Gustafsson J, Warner M, Roman G, et al. Defective cholesterol metabolism in amyotrophic lateral sclerosis. J Lipid Res. 2017;58(1):267\u201378.","journal-title":"J Lipid Res"},{"issue":"9","key":"228_CR12","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1001\/jamaneurol.2014.1129","volume":"71","author":"A Chio","year":"2014","unstructured":"Chio A, Calvo A, Bovio G, Canosa A, Bertuzzo D, Galmozzi F, et al. Amyotrophic lateral sclerosis outcome measures and the role of albumin and creatinine: a population-based study. JAMA Neurol. 2014;71(9):1134\u201342.","journal-title":"JAMA Neurol"},{"issue":"1\u20132","key":"228_CR13","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1080\/21678421.2018.1550516","volume":"20","author":"X Chen","year":"2019","unstructured":"Chen X, Wei QQ, Chen Y, Cao B, Ou R, Hou Y, et al. Clinical disease stage related changes of serological factors in amyotrophic lateral sclerosis. Amyotroph Lateral Scler Frontotemporal Degener. 2019;20(1\u20132):53\u201360.","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener."},{"issue":"12","key":"228_CR14","doi-asserted-by":"publisher","first-page":"2177","DOI":"10.1007\/s10072-017-3138-8","volume":"38","author":"J Mandrioli","year":"2017","unstructured":"Mandrioli J, Rosi E, Fini N, Fasano A, Raggi S, Fantuzzi A, et al. Changes in routine laboratory tests and survival in amyotrophic lateral sclerosis. Neurol Sci. 2017;38(12):2177\u201382.","journal-title":"Neurol Sci"},{"key":"228_CR15","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.freeradbiomed.2018.09.033","volume":"133","author":"S Masaldan","year":"2019","unstructured":"Masaldan S, Bush AI, Devos D, Rolland AS, Moreau C. Striking while the iron is hot: Iron metabolism and ferroptosis in neurodegeneration. Free Radic Biol Med. 2019;133:221\u201333.","journal-title":"Free Radic Biol Med"},{"issue":"2","key":"228_CR16","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1111\/ane.12708","volume":"136","author":"Y Zheng","year":"2017","unstructured":"Zheng Y, Gao L, Wang D, Zang D. Elevated levels of ferritin in the cerebrospinal fluid of amyotrophic lateral sclerosis patients. Acta Neurol Scand. 2017;136(2):145\u201350.","journal-title":"Acta Neurol Scand"},{"issue":"4","key":"228_CR17","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000000244","volume":"3","author":"CH Lu","year":"2016","unstructured":"Lu CH, Allen K, Oei F, Leoni E, Kuhle J, Tree T, et al. Systemic inflammatory response and neuromuscular involvement in amyotrophic lateral sclerosis. Neurol Neuroimmunol Neuroinflamm. 2016;3(4):e244.","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"12","key":"228_CR18","doi-asserted-by":"publisher","first-page":"2952","DOI":"10.1007\/s00415-019-09507-6","volume":"266","author":"D Ito","year":"2019","unstructured":"Ito D, Hashizume A, Hijikata Y, Yamada S, Iguchi Y, Iida M, et al. Elevated serum creatine kinase in the early stage of sporadic amyotrophic lateral sclerosis. J Neurol. 2019;266(12):2952\u201361.","journal-title":"J Neurol"},{"key":"228_CR19","doi-asserted-by":"publisher","first-page":"546","DOI":"10.3389\/fneur.2017.00546","volume":"8","author":"P Andr\u00e9s-Benito","year":"2017","unstructured":"Andr\u00e9s-Benito P, Moreno J, Dom\u00ednguez R, Aso E, Povedano M, Ferrer I. Inflammatory gene expression in whole peripheral blood at early stages of sporadic amyotrophic lateral sclerosis. Front Neurol. 2017;8:546.","journal-title":"Front Neurol"},{"issue":"9","key":"228_CR20","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1016\/S0891-5849(02)00784-0","volume":"32","author":"S Wendt","year":"2002","unstructured":"Wendt S, Dedeoglu A, Speer O, Wallimann T, Beal MF, Andreassen OA. Reduced creatine kinase activity in transgenic amyotrophic lateral sclerosis mice. Free Radic Biol Med. 2002;32(9):920\u20136.","journal-title":"Free Radic Biol Med"},{"issue":"7","key":"228_CR21","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1000097","volume":"6","author":"D Moher","year":"2009","unstructured":"Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;6(7):e1000097.","journal-title":"PLoS Med"},{"key":"228_CR22","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1186\/1471-2288-14-135","volume":"14","author":"X Wan","year":"2014","unstructured":"Wan X, Wang W, Liu J, Tong T. Estimating the sample mean and standard deviation from the sample size, median, range and\/or interquartile range. BMC Med Res Methodol. 2014;14:135.","journal-title":"BMC Med Res Methodol"},{"key":"228_CR23","doi-asserted-by":"crossref","unstructured":"Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al. Cochrane Handbook for Systematic Reviews of Interventions. Hoboken: Wiley; 2019. https:\/\/onlinelibrary.wiley.com\/doi\/abs\/10.1002\/9781119536604.ch12.","DOI":"10.1002\/9781119536604"},{"key":"228_CR24","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/1745-6215-8-16","volume":"8","author":"JF Tierney","year":"2007","unstructured":"Tierney JF, Stewart LA, Ghersi D, Burdett S, Sydes MR. Practical methods for incorporating summary time-to-event data into meta-analysis. Trials. 2007;8:16.","journal-title":"Trials."},{"issue":"24","key":"228_CR25","doi-asserted-by":"publisher","first-page":"4321","DOI":"10.1002\/sim.2692","volume":"25","author":"M Mittlb\u00f6ck","year":"2006","unstructured":"Mittlb\u00f6ck M, Heinzl H. A simulation study comparing properties of heterogeneity measures in meta-analyses. Stat Med. 2006;25(24):4321\u201333.","journal-title":"Stat Med"},{"issue":"7129","key":"228_CR26","first-page":"470","volume":"316","author":"L Irwig","year":"1998","unstructured":"Irwig L, Macaskill P, Berry G, Glasziou P. Bias in meta-analysis detected by a simple, graphical test. Graphical test is itself biased. BMJ. 1998;316(7129):470 author reply 470-1.","journal-title":"BMJ"},{"issue":"7","key":"228_CR27","doi-asserted-by":"publisher","first-page":"1865","DOI":"10.1007\/s10072-020-04292-x","volume":"41","author":"Y Wu","year":"2020","unstructured":"Wu Y, Yang X, Li X, Wang H, Wang T. Elevated cerebrospinal fluid homocysteine is associated with blood-brain barrier disruption in amyotrophic lateral sclerosis patients. Neurol Sci. 2020;41(7):1865\u201372.","journal-title":"Neurol Sci"},{"issue":"4","key":"228_CR28","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1002\/ana.25681","volume":"87","author":"C Grunseich","year":"2020","unstructured":"Grunseich C, Patankar A, Amaya J, Watts JA, Li D, Ramirez P, et al. Clinical and molecular aspects of senataxin mutations in amyotrophic lateral sclerosis 4. Ann Neurol. 2020;87(4):547\u201355.","journal-title":"Ann Neurol"},{"issue":"8","key":"228_CR29","doi-asserted-by":"publisher","first-page":"5729","DOI":"10.1007\/s12035-019-1482-9","volume":"56","author":"J Costa","year":"2019","unstructured":"Costa J, Streich L, Pinto S, Pronto-Laborinho A, Nimtz M, Conradt HS, et al. Exploring cerebrospinal fluid igg n-glycosylation as potential biomarker for amyotrophic lateral sclerosis. Mol Neurobiol. 2019;56(8):5729\u201339.","journal-title":"Mol Neurobiol"},{"issue":"16","key":"228_CR30","doi-asserted-by":"publisher","first-page":"e1868","DOI":"10.1212\/WNL.0000000000007311","volume":"92","author":"KMDP Ikenaka","year":"2019","unstructured":"Ikenaka KMDP, Atsuta NMDP, Maeda YP, Hotta YP, Nakamura RMDP, Kawai KP, et al. Increase of arginine dimethylation correlates with the progression and prognosis of ALS. Neurology. 2019;92(16):e1868\u2013e77.","journal-title":"Neurology."},{"issue":"3\u20134","key":"228_CR31","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1080\/21678421.2018.1555599","volume":"20","author":"Q Sun","year":"2019","unstructured":"Sun Q, Yang F, Wang H, Cui F, Li Y, Li S, et al. Elevated serum ferritin level as a predictor of reduced survival in patients with sporadic amyotrophic lateral sclerosis in China: a retrospective study. Amyotroph Lateral Scler Frontotemporal Degener. 2019;20(3\u20134):186\u201391.","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener."},{"issue":"11","key":"228_CR32","doi-asserted-by":"crossref","first-page":"e1205","DOI":"10.1212\/WNL.0000000000007097","volume":"92","author":"V Lombardi","year":"2019","unstructured":"Lombardi V, Querin G, Ziff OJ, Zampedri L, Martinelli I, Heller C, et al. Muscle and not neuronal biomarkers correlate with severity in spinal and bulbar muscular atrophy. Neurology. 2019;92(11):e1205\u2013e11.","journal-title":"Neurology."},{"key":"228_CR33","doi-asserted-by":"publisher","first-page":"5678698","DOI":"10.1155\/2018\/5678698","volume":"2018","author":"A Barros","year":"2018","unstructured":"Barros A, Dourado MET Jr, Pedrosa LFC, Leite-Lais L. Association of copper status with lipid profile and functional status in patients with amyotrophic lateral sclerosis. J Nutr Metab. 2018;2018:5678698.","journal-title":"J Nutr Metab"},{"issue":"3","key":"228_CR34","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1007\/s00415-017-8730-6","volume":"265","author":"D Rossi","year":"2018","unstructured":"Rossi D, Volanti P, Brambilla L, Colletti T, Spataro R, La Bella V. CSF neurofilament proteins as diagnostic and prognostic biomarkers for amyotrophic lateral sclerosis. J Neurol. 2018;265(3):510\u201321.","journal-title":"J Neurol"},{"issue":"8","key":"228_CR35","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.17219\/acem\/70441","volume":"27","author":"A Ku\u0142akowska","year":"2018","unstructured":"Ku\u0142akowska A, Tarasiuk J, Kapica-Topczewska K, Chor\u0105\u017cy M, Pogorzelski R, Kulczy\u0144ska-Przybik A, et al. Pathophysiological implications of actin-free Gc-globulin concentration changes in blood plasma and cerebrospinal fluid collected from patients with Alzheimer's disease and other neurological disorders. Adv Clin Exp Med. 2018;27(8):1075\u201380.","journal-title":"Adv Clin Exp Med"},{"issue":"4","key":"228_CR36","first-page":"333","volume":"9","author":"J Yu","year":"2018","unstructured":"Yu J, Wang N, Qi F, Wang X, Zhu Q, Lu Y, et al. Serum ferritin is a candidate biomarker of disease aggravation in amyotrophic lateral sclerosis. Biomed Rep. 2018;9(4):333\u20138.","journal-title":"Biomed Rep"},{"issue":"7","key":"228_CR37","doi-asserted-by":"publisher","first-page":"11855","DOI":"10.18632\/oncotarget.14416","volume":"8","author":"SM Kim","year":"2017","unstructured":"Kim SM, Noh MY, Kim H, Cheon SY, Lee KM, Lee J, et al. 25-Hydroxycholesterol is involved in the pathogenesis of amyotrophic lateral sclerosis. Oncotarget. 2017;8(7):11855\u201367.","journal-title":"Oncotarget."},{"key":"228_CR38","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.jns.2017.07.019","volume":"380","author":"JB Delaye","year":"2017","unstructured":"Delaye JB, Patin F, Piver E, Bruno C, Vasse M, Vourc'h P, et al. Low IDL-B and high LDL-1 subfraction levels in serum of ALS patients. J Neurol Sci. 2017;380:124\u20137.","journal-title":"J Neurol Sci"},{"issue":"3","key":"228_CR39","first-page":"104","volume":"21","author":"M Nagase","year":"2016","unstructured":"Nagase M, Yamamoto Y, Miyazaki Y, Yoshino H. Increased oxidative stress in patients with amyotrophic lateral sclerosis and the effect of edaravone administration. Redox Rep. 2016;21(3):104\u201312.","journal-title":"Redox Rep"},{"issue":"3","key":"228_CR40","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1007\/s00702-015-1486-1","volume":"123","author":"E Feneberg","year":"2016","unstructured":"Feneberg E, Steinacker P, Volk AE, Weishaupt JH, Wollmer MA, Boxer A, et al. Progranulin as a candidate biomarker for therapeutic trial in patients with ALS and FTLD. J Neural Transm (Vienna). 2016;123(3):289\u201396.","journal-title":"J Neural Transm (Vienna)"},{"issue":"7","key":"228_CR41","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0131512","volume":"10","author":"A Henriques","year":"2015","unstructured":"Henriques A, Blasco H, Fleury MC, Corcia P, Echaniz-Laguna A, Robelin L, et al. Blood cell palmitoleate-palmitate ratio is an independent prognostic factor for amyotrophic lateral sclerosis. PLoS One. 2015;10(7):e0131512.","journal-title":"PLoS One"},{"issue":"1\/2","key":"228_CR42","doi-asserted-by":"publisher","first-page":"102","DOI":"10.3109\/21678421.2014.984723","volume":"16","author":"XW Su","year":"2015","unstructured":"Su XW, Clardy SL, Stephens HE, Simmons Z, Connor JR. Serum ferritin is elevated in amyotrophic lateral sclerosis patients. Amyotroph Lateral Scler Frontotemporal Degener. 2015;16(1\/2):102\u20137.","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener."},{"issue":"2","key":"228_CR43","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0089596","volume":"9","author":"C May","year":"2014","unstructured":"May C, Nordhoff E, Casjens S, Turewicz M, Eisenacher M, Gold R, et al. Highly immunoreactive IgG antibodies directed against a set of twenty human proteins in the sera of patients with amyotrophic lateral sclerosis identified by protein array. PLoS One. 2014;9(2):e89596.","journal-title":"PLoS One"},{"key":"228_CR44","doi-asserted-by":"crossref","unstructured":"Wuolikainen A, Acimovic J, L\u00f6vgren-Sandblom A, Parini P, Andersen PM, Bj\u00f6rkhem I. Cholesterol, oxysterol, triglyceride, and coenzyme Q homeostasis in ALS. Evidence against the hypothesis that elevated 27-hydroxycholesterol is a pathogenic factor. PLoS One. 2014;9(11):e113619.","DOI":"10.1371\/journal.pone.0113619"},{"issue":"9934","key":"228_CR45","doi-asserted-by":"publisher","first-page":"2065","DOI":"10.1016\/S0140-6736(14)60222-1","volume":"383","author":"AM Wills","year":"2014","unstructured":"Wills AM, Hubbard J, Macklin EA, Glass J, Tandan R, Simpson EP, et al. Hypercaloric enteral nutrition in patients with amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled phase 2 trial. Lancet. 2014;383(9934):2065\u201372.","journal-title":"Lancet."},{"issue":"5\u20136","key":"228_CR46","doi-asserted-by":"publisher","first-page":"359","DOI":"10.3109\/21678421.2015.1047454","volume":"16","author":"R Huang","year":"2015","unstructured":"Huang R, Guo X, Chen X, Zheng Z, Wei Q, Cao B, et al. The serum lipid profiles of amyotrophic lateral sclerosis patients: a study from south-West China and a meta-analysis. Amyotroph Lateral Scler Frontotemporal Degener. 2015;16(5\u20136):359\u201365.","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener"},{"issue":"13","key":"228_CR47","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1212\/WNL.0000000000000274","volume":"82","author":"HPP Blasco","year":"2014","unstructured":"Blasco HPP, Nadal-Desbarats LP, Pradat P-FMDP, Gordon PHMDP, Antar C, Veyrat-Durebex CP, et al. Untargeted 1H-NMR metabolomics in CSF: toward a diagnostic biomarker for motor neuron disease. Neurology. 2014;82(13):1167\u201374.","journal-title":"Neurology."},{"key":"228_CR48","doi-asserted-by":"publisher","first-page":"485723","DOI":"10.1155\/2014\/485723","volume":"2014","author":"C Veyrat-Durebex","year":"2014","unstructured":"Veyrat-Durebex C, Corcia P, Mucha A, Benzimra S, Mallet C, Gendrot C, et al. Iron metabolism disturbance in a French cohort of ALS patients. Biomed Res Int. 2014;2014:485723.","journal-title":"Biomed Res Int"},{"issue":"2","key":"228_CR49","doi-asserted-by":"publisher","first-page":"125","DOI":"10.3988\/jcn.2013.9.2.125","volume":"9","author":"JW Yang","year":"2013","unstructured":"Yang JW, Kim SM, Kim HJ, Kim JE, Park KS, Kim SH, et al. Hypolipidemia in patients with amyotrophic lateral sclerosis: a possible gender difference? J Clin Neurol. 2013;9(2):125\u20139.","journal-title":"J Clin Neurol"},{"issue":"1","key":"228_CR50","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1007\/s00415-012-6589-0","volume":"260","author":"N Ticozzi","year":"2013","unstructured":"Ticozzi N, Tiloca C, Mencacci NE, Morelli C, Doretti A, Rusconi D, et al. Oligoclonal bands in the cerebrospinal fluid of amyotrophic lateral sclerosis patients with disease-associated mutations. J Neurol. 2013;260(1):85\u201392.","journal-title":"J Neurol"},{"issue":"12","key":"228_CR51","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.2169\/internalmedicine.51.7465","volume":"51","author":"K Ikeda","year":"2012","unstructured":"Ikeda K, Hirayama T, Takazawa T, Kawabe K, Iwasaki Y. Relationships between disease progression and serum levels of lipid, urate, creatinine and ferritin in Japanese patients with amyotrophic lateral sclerosis: a cross-sectional study. Intern Med. 2012;51(12):1501\u20138.","journal-title":"Intern Med"},{"issue":"9","key":"228_CR52","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0045034","volume":"7","author":"Y Nadjar","year":"2012","unstructured":"Nadjar Y, Gordon P, Corcia P, Bensimon G, Pieroni L, Meininger V, et al. Elevated serum ferritin is associated with reduced survival in amyotrophic lateral sclerosis. PLoS One. 2012;7(9):1\u20136.","journal-title":"PLoS One"},{"issue":"6","key":"228_CR53","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1136\/jnnp.2010.236752","volume":"82","author":"NA Sutedja","year":"2011","unstructured":"Sutedja NA, van der Schouw YT, Fischer K, Sizoo EM, Huisman MH, Veldink JH, et al. Beneficial vascular risk profile is associated with amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry. 2011;82(6):638\u201342.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"7","key":"228_CR54","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1007\/s11064-010-0156-9","volume":"35","author":"SD S\u00fcssmuth","year":"2010","unstructured":"S\u00fcssmuth SD, Sperfeld AD, Ludolph AC, Tumani H. Hypercapnia is a possible determinant of the function of the blood-cerebrospinal fluid barrier in amyotrophic lateral sclerosis. Neurochem Res. 2010;35(7):1071\u20134.","journal-title":"Neurochem Res"},{"issue":"1","key":"228_CR55","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1002\/mus.21625","volume":"42","author":"RM Mitchell","year":"2010","unstructured":"Mitchell RM, Simmons Z, Beard JL, Stephens HE, Connor JR. Plasma biomarkers associated with ALS and their relationship to iron homeostasis. Muscle Nerve. 2010;42(1):95\u2013103.","journal-title":"Muscle Nerve"},{"issue":"20","key":"228_CR56","doi-asserted-by":"publisher","first-page":"1681","DOI":"10.1212\/WNL.0b013e3181c1df1e","volume":"73","author":"A Chio","year":"2009","unstructured":"Chio A, Calvo A, Ilardi A, Cavallo E, Moglia C, Mutani R, et al. Lower serum lipid levels are related to respiratory impairment in patients with ALS. Neurology. 2009;73(20):1681\u20135.","journal-title":"Neurology."},{"issue":"13","key":"228_CR57","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1212\/01.wnl.0000285080.70324.27","volume":"70","author":"L Dupuis","year":"2008","unstructured":"Dupuis L, Corcia P, Fergani A, De Aguilar JL, Bonnefont-Rousselot D, Bittar R, et al. Dyslipidemia is a protective factor in amyotrophic lateral sclerosis. Neurology. 2008;70(13):1004\u20139.","journal-title":"Neurology."},{"key":"228_CR58","doi-asserted-by":"publisher","first-page":"51","DOI":"10.2174\/1874205X00802010051","volume":"2","author":"M Qureshi","year":"2008","unstructured":"Qureshi M, Brown RH Jr, Rogers JT, Cudkowicz ME. Serum ferritin and metal levels as risk factors for amyotrophic lateral sclerosis. Open Neurol J. 2008;2:51\u20134.","journal-title":"Open Neurol J"},{"issue":"11","key":"228_CR59","doi-asserted-by":"publisher","first-page":"1652","DOI":"10.1007\/s00415-008-0945-0","volume":"255","author":"EF Goodall","year":"2008","unstructured":"Goodall EF, Haque MS, Morrison KE. Increased serum ferritin levels in amyotrophic lateral sclerosis (ALS) patients. J Neurology. 2008;255(11):1652\u20136.","journal-title":"J Neurology"},{"issue":"1","key":"228_CR60","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.jns.2004.09.030","volume":"228","author":"M Sohmiya","year":"2005","unstructured":"Sohmiya M, Tanaka M, Suzuki Y, Tanino Y, Okamoto K, Yamamoto Y. An increase of oxidized coenzyme Q-10 occurs in the plasma of sporadic ALS patients. J Neurol Sci. 2005;228(1):49\u201353.","journal-title":"J Neurol Sci"},{"issue":"1\u20132","key":"228_CR61","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/S0165-5728(00)00339-8","volume":"110","author":"M Yushchenko","year":"2000","unstructured":"Yushchenko M, Weber F, M\u00e4der M, Sch\u00f6ll U, Maliszewska M, Tumani H, et al. Matrix metalloproteinase-9 (MMP-9) in human cerebrospinal fluid (CSF): elevated levels are primarily related to CSF cell count. J Neuroimmunol. 2000;110(1\u20132):244\u201351.","journal-title":"J Neuroimmunol"},{"issue":"2","key":"228_CR62","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1111\/j.1600-0404.1992.tb04003.x","volume":"85","author":"AC Ludolph","year":"1992","unstructured":"Ludolph AC, Langen KJ, Regard M, Herzog H, Kemper B, Kuwert T, et al. Frontal lobe function in amyotrophic lateral sclerosis: a neuropsychologic and positron emission tomography study. Acta Neurol Scand. 1992;85(2):81\u20139.","journal-title":"Acta Neurol Scand"},{"issue":"1","key":"228_CR63","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1210\/jcem-63-1-41","volume":"63","author":"MD Harris","year":"1986","unstructured":"Harris MD, Davidson MB, Rosenberg CS. Insulin antagonism is not a primary abnormality of amyotrophic lateral sclerois but is related to disease severity. J Clin Endocrinol Metab. 1986;63(1):41\u20136.","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"228_CR64","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1007\/BF00313786","volume":"232","author":"E Jockers-Wretou","year":"1985","unstructured":"Jockers-Wretou E, Vassilopoulos D. Serum creatine kinase B subunit levels in neurogenic atrophies. J Neurol. 1985;232(4):236\u20139.","journal-title":"J Neurol"},{"issue":"3","key":"228_CR65","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/0022-510X(84)90154-0","volume":"63","author":"ET Reyes","year":"1984","unstructured":"Reyes ET, Perurena OH, Festoff BW, Jorgensen R, Moore WV. Insulin resistance in amyotrophic lateral sclerosis. J Neurol Sci. 1984;63(3):317\u201324.","journal-title":"J Neurol Sci"},{"issue":"4","key":"228_CR66","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1620\/tjem.139.365","volume":"139","author":"A Murai","year":"1983","unstructured":"Murai A, Miyahara T, Tanaka T, Kaneko T, Sako Y, Kameyama M. Abnormalities of lipoprotein and carbohydrate metabolism in degenerative diseases of the nervous system--motor neuron disease and spinocerebellar degeneration. Tohoku J Exp Med. 1983;139(4):365\u201376.","journal-title":"Tohoku J Exp Med"},{"issue":"6","key":"228_CR67","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1042\/cs0640601","volume":"64","author":"RT Moxley","year":"1983","unstructured":"Moxley RT, Griggs RC, Forbes GB, Goldblatt D, Donohoe K. Influence of muscle wasting on oral glucose tolerance testing. Clin Sci (Lond). 1983;64(6):601\u20139.","journal-title":"Clin Sci (Lond)"},{"issue":"1","key":"228_CR68","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/S1474-4422(10)70224-6","volume":"10","author":"L Dupuis","year":"2011","unstructured":"Dupuis L, Pradat PF, Ludolph AC, Loeffler JP. Energy metabolism in amyotrophic lateral sclerosis. Lancet Neurol. 2011;10(1):75\u201382.","journal-title":"Lancet Neurol"},{"key":"228_CR69","doi-asserted-by":"publisher","first-page":"100867","DOI":"10.1016\/j.mam.2020.100867","volume":"75","author":"Y Kim","year":"2020","unstructured":"Kim Y, Connor JR. The roles of iron and HFE genotype in neurological diseases. Mol Asp Med. 2020;75:100867.","journal-title":"Mol Asp Med"},{"issue":"3","key":"228_CR70","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.blre.2008.08.001","volume":"23","author":"MA Knovich","year":"2009","unstructured":"Knovich MA, Storey JA, Coffman LG, Torti SV, Torti FM. Ferritin for the clinician. Blood Rev. 2009;23(3):95\u2013104.","journal-title":"Blood Rev"},{"issue":"3","key":"228_CR71","doi-asserted-by":"publisher","first-page":"301","DOI":"10.4103\/0976-3147.102611","volume":"3","author":"AV Singh","year":"2012","unstructured":"Singh AV, Vyas V, Montani E, Cartelli D, Parazzoli D, Oldani A, et al. Investigation of in vitro cytotoxicity of the redox state of ionic iron in neuroblastoma cells. J Neurosci Rural Pract. 2012;3(3):301\u201310.","journal-title":"J Neurosci Rural Pract"},{"issue":"4","key":"228_CR72","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/S0891-5849(02)00842-0","volume":"33","author":"P Arosio","year":"2002","unstructured":"Arosio P, Levi S. Ferritin, iron homeostasis, and oxidative damage. Free Radic Biol Med. 2002;33(4):457\u201363.","journal-title":"Free Radic Biol Med"},{"issue":"3","key":"228_CR73","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1038\/s41419-018-0379-2","volume":"9","author":"S Sheykhansari","year":"2018","unstructured":"Sheykhansari S, Kozielski K, Bill J, Sitti M, Gemmati D, Zamboni P, et al. Redox metals homeostasis in multiple sclerosis and amyotrophic lateral sclerosis: a review. Cell Death Dis. 2018;9(3):348.","journal-title":"Cell Death Dis"},{"issue":"4","key":"228_CR74","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1039\/C3MT00347G","volume":"6","author":"DB Kell","year":"2014","unstructured":"Kell DB, Pretorius E. Serum ferritin is an important inflammatory disease marker, as it is mainly a leakage product from damaged cells. Metallomics. 2014;6(4):748\u201373.","journal-title":"Metallomics."},{"issue":"8","key":"228_CR75","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1038\/nri3863","volume":"15","author":"T Ganz","year":"2015","unstructured":"Ganz T, Nemeth E. Iron homeostasis in host defence and inflammation. Nat Rev Immunol. 2015;15(8):500\u201310.","journal-title":"Nat Rev Immunol"},{"issue":"3","key":"228_CR76","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0193867","volume":"13","author":"V Tisato","year":"2018","unstructured":"Tisato V, Zuliani G, Vigliano M, Longo G, Franchini E, Secchiero P, et al. Gene-gene interactions among coding genes of iron-homeostasis proteins and APOE-alleles in cognitive impairment diseases. PLoS One. 2018;13(3):e0193867.","journal-title":"PLoS One"},{"key":"228_CR77","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1186\/1471-2350-13-70","volume":"13","author":"D Gemmati","year":"2012","unstructured":"Gemmati D, Zeri G, Orioli E, De Gaetano FE, Salvi F, Bartolomei I, et al. Polymorphisms in the genes coding for iron binding and transporting proteins are associated with disability, severity, and early progression in multiple sclerosis. BMC Med Genet. 2012;13:70.","journal-title":"BMC Med Genet"},{"issue":"1","key":"228_CR78","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1148\/radiol.2018180112","volume":"289","author":"J Acosta-Cabronero","year":"2018","unstructured":"Acosta-Cabronero J, Machts J, Schreiber S, Abdulla S, Kollewe K, Petri S, et al. Quantitative susceptibility MRI to detect brain iron in amyotrophic lateral sclerosis. Radiology. 2018;289(1):195\u2013203.","journal-title":"Radiology."},{"issue":"3","key":"228_CR79","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1111\/jon.12127","volume":"25","author":"Y Adachi","year":"2015","unstructured":"Adachi Y, Sato N, Saito Y, Kimura Y, Nakata Y, Ito K, et al. Usefulness of SWI for the detection of iron in the motor cortex in amyotrophic lateral sclerosis. J Neuroimaging. 2015;25(3):443\u201351.","journal-title":"J Neuroimaging"},{"issue":"2","key":"228_CR80","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1007\/s12640-016-9677-6","volume":"31","author":"S Golko-Perez","year":"2017","unstructured":"Golko-Perez S, Amit T, Bar-Am O, Youdim MB, Weinreb O. A novel iron chelator-radical scavenger ameliorates motor dysfunction and improves life span and mitochondrial biogenesis in SOD1(G93A) ALS mice. Neurotox Res. 2017;31(2):230\u201344.","journal-title":"Neurotox Res"},{"issue":"8","key":"228_CR81","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1089\/ars.2017.7493","volume":"29","author":"C Moreau","year":"2018","unstructured":"Moreau C, Danel V, Devedjian JC, Grolez G, Timmerman K, Laloux C, et al. Could conservative iron chelation lead to neuroprotection in amyotrophic lateral sclerosis? Antioxid Redox Signal. 2018;29(8):742\u20138.","journal-title":"Antioxid Redox Signal"},{"issue":"2","key":"228_CR82","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1007\/s00702-019-02138-1","volume":"127","author":"D Devos","year":"2020","unstructured":"Devos D, Cabantchik ZI, Moreau C, Danel V, Mahoney-Sanchez L, Bouchaoui H, et al. Conservative iron chelation for neurodegenerative diseases such as Parkinson's disease and amyotrophic lateral sclerosis. J Neural Transm (Vienna). 2020;127(2):189\u2013203.","journal-title":"J Neural Transm (Vienna)"},{"key":"228_CR83","doi-asserted-by":"publisher","first-page":"380","DOI":"10.3389\/fneur.2020.00380","volume":"11","author":"L Wang","year":"2020","unstructured":"Wang L, Li C, Chen X, Li S, Shang H. Abnormal serum iron-status indicator changes in amyotrophic lateral sclerosis (ALS) patients: a meta-analysis. Front Neurol. 2020;11:380.","journal-title":"Front Neurol"},{"issue":"5","key":"228_CR84","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1016\/j.clinph.2018.01.071","volume":"129","author":"H Tai","year":"2018","unstructured":"Tai H, Cui L, Liu M, Guan Y, Li X, Shen D, et al. Creatine kinase level and its relationship with quantitative electromyographic characteristics in amyotrophic lateral sclerosis. Clin Neurophysiol. 2018;129(5):926\u201330.","journal-title":"Clin Neurophysiol"},{"issue":"2","key":"228_CR85","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/0022-510X(75)90032-5","volume":"26","author":"TA Linkhart","year":"1975","unstructured":"Linkhart TA, Wilson BW. Appearance of acetylcholinesterase and creatine kinase in plasma of normal chickens after denervation. J Neurol Sci. 1975;26(2):193\u2013201.","journal-title":"J Neurol Sci"},{"issue":"2","key":"228_CR86","doi-asserted-by":"publisher","first-page":"168","DOI":"10.3109\/00365513.2010.547947","volume":"71","author":"A Borai","year":"2011","unstructured":"Borai A, Livingstone C, Abdelaal F, Bawazeer A, Keti V, Ferns G. The relationship between glycosylated haemoglobin (HbA1c) and measures of insulin resistance across a range of glucose tolerance. Scand J Clin Lab Invest. 2011;71(2):168\u201372.","journal-title":"Scand J Clin Lab Invest"},{"issue":"3","key":"228_CR87","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1093\/ajcn\/74.3.328","volume":"74","author":"JC Desport","year":"2001","unstructured":"Desport JC, Preux PM, Magy L, Boirie Y, Vallat JM, Beaufr\u00e8re B, et al. Factors correlated with hypermetabolism in patients with amyotrophic lateral sclerosis. Am J Clin Nutr. 2001;74(3):328\u201334.","journal-title":"Am J Clin Nutr"},{"issue":"3\u20134","key":"228_CR88","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1159\/000089626","volume":"2","author":"JC Desport","year":"2005","unstructured":"Desport JC, Torny F, Lacoste M, Preux PM, Couratier P. Hypermetabolism in ALS: correlations with clinical and paraclinical parameters. Neurodegener Dis. 2005;2(3\u20134):202\u20137.","journal-title":"Neurodegener Dis"},{"issue":"2","key":"228_CR89","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1080\/17482960802295192","volume":"10","author":"B Funalot","year":"2009","unstructured":"Funalot B, Desport JC, Sturtz F, Camu W, Couratier P. High metabolic level in patients with familial amyotrophic lateral sclerosis. Amyotroph Lateral Scler. 2009;10(2):113\u20137.","journal-title":"Amyotroph Lateral Scler"},{"issue":"4","key":"228_CR90","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1002\/jnr.23777","volume":"95","author":"MA Daulatzai","year":"2017","unstructured":"Daulatzai MA. Cerebral hypoperfusion and glucose hypometabolism: key pathophysiological modulators promote neurodegeneration, cognitive impairment, and Alzheimer's disease. J Neurosci Res. 2017;95(4):943\u201372.","journal-title":"J Neurosci Res"}],"container-title":["Translational Neurodegeneration"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40035-020-00228-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40035-020-00228-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40035-020-00228-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,22]],"date-time":"2024-08-22T02:14:33Z","timestamp":1724292873000},"score":1,"resource":{"primary":{"URL":"https:\/\/translationalneurodegeneration.biomedcentral.com\/articles\/10.1186\/s40035-020-00228-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,8]]},"references-count":90,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["228"],"URL":"https:\/\/doi.org\/10.1186\/s40035-020-00228-9","relation":{},"ISSN":["2047-9158"],"issn-type":[{"value":"2047-9158","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,8]]},"assertion":[{"value":"9 October 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 December 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 January 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"3"}}